ABBOTT LABORATORIES — Director's Dealing 2014

Mar 4, 2014

Page 1 of 2

SEC FORM 4

SEC Form 4

FORM 4

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number: 3235-0287 December 31, Expires: 2014 Estimated average burden hours per 0.5 response:

1. Name and Address of Reporting Person* Contreras Jaime (Last) (First) (Middle) 100 ABBOTT PARK ROAD (Street) ABBOTT PARK IL 60064 (City) (State) (Zip)

2. Issuer NameandTicker or Trading Symbol ABBOTT LABORATORIES[ABT] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Senior Vice President 3. Date of Earliest Transaction (Month/Day/Year) 02/28/2014 4. If Amendment, Date of Original Filed (Month/Day/Year) 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1. Title of Security (Instr. 3)	2. Transaction	2A. Deemed	3.			4. Securities Acquired (A)	4. Securities Acquired (A)	4. Securities Acquired (A)	5. Amount	6.	7. Nature of
	Date	Execution Date,	Transaction			or Disposed Of		(D) (Instr.	of	Ownership	Indirect
	(Month/Day/Year)	if any	Code		(Instr.	3, 4 and 5)			Securities	Form:	Beneficial
		(Month/Day/Year)	8)						Beneficially	Direct (D)	Ownership
									Owned	or Indirect	(Instr. 4)
									Following	(I) (Instr. 4)
			Code		V	Amount	(A) or (D)	Price	Reported Transaction (s) (Instr. 3 and 4)
Common shares without par value	02/28/2014			F		3,919	D	$39.79	38,217	D
Common shares without par value	03/03/2014			S		4,831	D	$39.366	33,386	D
Common shares without par value	03/03/2014			S		650	D	$39.37	32,736	D
Common shares without par value	03/03/2014			S		2,000	D	$39.381	30,736	D
Common shares without par value	03/03/2014			S		600	D	$39.384	30,136	D
											Profit
Common shares without par value									20 (1)	I	Sharing
											Trust
											Profit
Common shares without par value									16 (1)	I	Sharing Trust(by
											spouse)
											Jaime
											Contreras
Common shares without par value									63,903 (2)	I	Marvan 2006
											Living
											Trust
Common shares without par value									1,067 (3)	I	By spouse
											Living
Common shares without par value									12,081 (4)	I	Trust(by
											spouse)

3/4/2014

Page 2 of 2

SEC FORM 4

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of	2.	3. Transaction	3A. Deemed	4.		5.		6. Date Exercisable and	6. Date Exercisable and	7. Title and	8. Price of	9. Number	10.	11. Natu
Derivative	Conversion	Date	Execution Date,	Transaction		Number		Expiration Date		Amount of	Derivative	of	Ownership	of Indire
Security	or Exercise	(Month/Day/Year)	if any	Code	(Instr.	of		(Month/Day/Year)		Securities	Security	derivative	Form:	Benefici
(Instr. 3)	Price of		(Month/Day/Year)	8)		Derivative				Underlying	(Instr. 5)	Securities	Direct (D)	Ownersh
	Derivative					Securities				Derivative		Beneficially	or Indirect	(Instr. 4)
	Security					Acquired				Security		Owned	(I) (Instr. 4)
						(A) or				(Instr. 3 and 4)		Following
						Disposed						Reported
						of (D)						Transaction
						(Instr.	3, 4					(s) (Instr. 4)
						and 5)
										Amount
										or
										Number
								Date	Expiration	of
				Code	V	(A)	(D)	Exercisable	Date	Title Shares

Explanation of Responses:

1. Balance in the Abbott Laboratories Stock Retirement Trust as of February 28, 2014.

2. Held in the Jaime Contreras Marvan 2006 Living Trust. The reporting person is sole trustee of the trust. The trust is revocable.

3. The reporting person disclaims beneficial ownership of all securities held by his spouse.

4. Held in spouse's living trust. The reporting person's spouse is sole trustee of the trust. The trust is revocable. The reporting person disclaims beneficial ownership of these securities.

Remarks:

The sale transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).

John A. Berry, by power of attorney for Jaime 03/04/2014 Contreras

• ** Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

• If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

• ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

• Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

3/4/2014